FDA approves Boston Scientific's thrombectomy system:
This article was originally published in Clinica
Executive Summary
The US FDA has approved Boston Scientific's Oasis thrombectomy system is designed to remove blood clots which develop in the access grafts of haemodialysis patients. A low-pressure water jet breaks down the blood clot and washes away the debris from the haemodialysis graft. The system can be used with a standard angiographic injector, said the company.